News
1d
Medical Device Network on MSNFDA approves Abbott’s TMVR system to treat mitral valve diseaseThe system is available for patients whose mitral valves are not working properly due to severe mitral annular calcification.
1d
Health and Me on MSNNew Mitral Valve Replacement Device Wins FDA ApprovalThe Tendyne system is designated for those who are at high risk for traditional open-heart surgery. It helps with those with ...
Abbott announced the FDA approved its transcatheter mitral valve replacement system for patients with severe mitral annular ...
The approval is tightly defined: the system will be for patients ineligible for surgery and with anatomy unfavorable for TEER ...
Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...
US FDA approves Abbott’s Tendyne, first-of-its-kind device to replace the mitral valve without open-heart surgery: Abbott Park, Illinois Thursday, May 29, 2025, 16:00 Hrs [IST] ...
The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.
2d
MedPage Today on MSNTendyne TMVR Gets FDA Nod; Breastfeeding and ASCVD; Sudden Bodybuilder DeathsAbbott's Tendyne transcatheter mitral valve replacement (TMVR) system was approved by the FDA and indicated for those with ...
Abbott said the Tendyne system addresses a significant unmet need in cardiac care, providing an option for patients ineligible for open heart surgery and whose valves cannot be successfully repaired ...
The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...
"Mitral annular calcification stiffens the structure of the mitral valve and can lead to mitral regurgitation or stenosis that disrupt the heart's ability to pump blood effectively. These ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results